Opentrons
Opentrons Labworks Inc develops lab automation systems designed to handle repetitive liquid-handling tasks. The company offers modular hardware and software tools aimed at reducing manual pipetting and workflow bottlenecks in research labs.
Public-source profile · Company ownership not verified. Sources & corrections
The short feature · 1 min read
Opentrons, at a glance
Built for · Research labs in genomics, proteomics, nucleic acid extraction, and PCR workflows, as well as institutions exploring AI-driven experimentation.
Based on company material. Product claims are attributed to the company.
- 01
The problem
Manual pipetting and repetitive lab tasks consume significant time and introduce variability, limiting scalability and efficiency in research workflows. Labs often face bottlenecks when scaling experiments or adapting to new protocols.
Sources [1]
- 02
The product approach
Opentrons provides automated workstations, such as the Flex system, which integrate hardware (pipettes, modules) and software (no-code/low-code tools, Python API) to execute liquid-handling protocols. The system supports reconfigurable workflows for applications like NGS, proteomics, and PCR.
Sources [1]
- 03
What stands out
Unlike closed automation systems, Opentrons emphasizes flexibility by allowing users to reconfigure hardware, use third-party assays, and access open-source software (Python API). The platform includes tools like OpentronsAI for natural language protocol design and Protocol Designer for drag-and-drop workflow creation.
Sources [1]
What could be hard to replicate?
A useful product is not automatically a moat. These mechanisms need evidence of a lasting advantage.
Technology & IP
Company claimOpen-source Python API enables customization and integration with existing lab tools, reducing dependency on proprietary systems.
Mechanism → evidence check
What prevents another team from reproducing the capability?
Sources [1]
Data advantage
Company claimProtocol Library offers pre-verified and community-shared protocols, lowering the barrier to adoption for new users.
Mechanism → evidence check
Does exclusive data improve the product in a way competitors cannot reproduce?
Sources [1]
The question to watch
The material claims AI-enabled protocol optimization and simulation, but it is unclear how OpentronsAI’s natural language processing compares to manual protocol design in terms of accuracy, error rates, or real-world validation across diverse lab workflows.
Explore the evidence · 1 source
- [1] Opentrons company website
Company material · checked 30/10/2026
science, fewer bottlenecks Automation handles repetitive work so teams can focus on analysis, collaboration, and solving harder problems as experiments scale. One platform, many directions…
About
Opentrons Labworks Inc., a leader in artificial intelligence-driven robotic laboratory automation, today announced it has raised $40 million in new funding to scale its robotics, software and data infrastructure tools. Healthcare investor Avego led the Series E round alongside BroadOak Capital Partners.
Profile sources, ownership & corrections
Company ownership is not verified
This profile was compiled from public sources and hasn't been verified by Opentrons. Claim it to correct the details, add your team and funding history, and request review of your company information.
Compiled from news coverage, the company's own website.
Similar startups
Global manufacturers in energy, electric vehicles, aerospace, and defense face supply chain risks due to reliance on imported components.
Accounting, tax, and audit firms face inefficiencies in client service delivery due to fragmented knowledge across teams, documents, and systems.
AvalonX offers AI-driven continuous offensive security testing for businesses.
Electronic hardware design involves thousands of interdependent decisions, from component selection to schematic validation.